Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Stroke Rehabilitation and Recovery, and Intracerebral and Subarachnoid Hemorrhage Research.
Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications.
Temporal Dynamics of the No-Reflow Phenomenon on Serial Perfusion MRI After Thrombectomy.
Educational impact of 3D-printed models in enhancing endoscopic intracerebral hemorrhage removal: An international survey based on the EVACUATE trial.
Glycoprotein IIb/IIIa Agents in Acute Ischemic Stroke: A Niche in the Making?
Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy-A secondary analysis of the TRACE-III randomized trial.
Reporting and Analysis of Process-of-Care Time Measures for Hyperacute Stroke Interventions.
Calibrated non-inferiority margin: a new pragmatic method to account for population shift in stroke trials.
Use of Imaging to Guide Eligibility for Reperfusion Therapies in Acute Ischemic Stroke.
Microcirculatory Collaterals Modulate Ischemic Core Heterogeneity on Diffusion-Weighted Imaging.
Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial.
Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.
Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum.
Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial.
ADJUVANT Randomized Controlled Trial: Rationale and Design.
Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized Trial.
Optimizing Reperfusion Trials: A Consensus Research Roadmap From the STAIR XIII Conference.
Use of Imaging to Guide Eligibility for Reperfusion Therapies in Acute Ischemic Stroke
Accuracy of Distal Internal Carotid Artery Contrast Ratio to Infer Proximal Carotid Disease in the Mobile Stroke Unit
Intravenous Tenecteplase before Thrombectomy in Stroke
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
Endovascular Thrombectomy for Large Ischemic Core Stroke
Cerebral Infarct Growth: Pathophysiology, Pragmatic Assessment, and Clinical Implications.
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours.
Endovascular Thrombectomy for Large Ischemic Core Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy.
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access)
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial.